Vulvakarzinom

  • H. G. Schnürch
  • H. G. Meerpohl
Chapter

Zusammenfassung

Häufigkeit: Das Vulvakarzinom ist mit einem Anteil von 3–5% an den malignen Tumoren des weiblichen Genitaltrakts ein seltener Tumor. Typischerweise handelt es sich um Plattenepithelkarzinome. Melanome, Adenokarzinome oder Sarkome der Vulva sind sehr selten.

This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adamson R, Jones AS, Field JK (1994) Loss of heterocygocity studies on chromosome 17 in head and neck cancer using microsatellite markers. Oncogene 9:2077–2082PubMedGoogle Scholar
  2. Belinson JL, Stewart JA, Richards A et al (1985) Bleomycin, vincristine, mitomycin C, and cisplatin in the management of gynecologic squamous cell cancer. Gynecol Oncol 20:387PubMedCrossRefGoogle Scholar
  3. Berek JS, Heaps J, Fu YS et al (1991) Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecol Oncol 42:197–201PubMedCrossRefGoogle Scholar
  4. Boronow RC, Hickmann BT, Reagan MT et al (1987) Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer. II. Results, complications and dosimetric and surgical considerations. Am J Clin Oncol 10:171PubMedCrossRefGoogle Scholar
  5. Brinton LA, Nasca PC, Mallin K et al (1990) Case control study of cancer of the vulva. Obstet Gynecol 75:859PubMedGoogle Scholar
  6. Chafe W, Richard A, Morgan L et al (1988) Unrecognized invasive carcinoma in vulvar epithelial neoplasia (VIN). Gynecol Oncol 31:154PubMedCrossRefGoogle Scholar
  7. Creasman WT, Phillips JL, Menck HR (1997) The National Cancer Data Base Report on early stage invasive vulvar carcinoma. Cancer 80:505–513PubMedCrossRefGoogle Scholar
  8. Creasman WT (1990) New gynecologic cancer staging. Obstet Gynecol 75:287PubMedGoogle Scholar
  9. Crum CP (1992) Carcinoma of the vulva. Epidemiology and pathogenesis. Obstet Gynecol 79:448–458PubMedCrossRefGoogle Scholar
  10. De Cesare S, Roberts W, Reintgen D et al (1997) A pilot study utilizing intraoperative lymphscintigraphy for identification of the sentinel nodes in vulvar cancer. Gynecol Oncol 66:425–428CrossRefGoogle Scholar
  11. De Cicco C, Sideri M, Bartolomei M et al (2000) Sentinel node biopsy in vulvar cancer. Br J Cancer 82:295–299PubMedCrossRefGoogle Scholar
  12. De Hullu JA, Hollema H, Piers DA et al (2000) Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 18:2811–2816PubMedGoogle Scholar
  13. Deppe G, Bruckner HW, Cohen CJ (1977) Adriamycin treatment of advanced vulvar carcinoma. Obstet Gynecol 50 [Suppl 10]:13Google Scholar
  14. Deutsche Krebsgesellschaft (2002) Diagnostik und Therapie maligner Erkrankungen. Kurzgefaßte interdisziplinäre Leitlinien 2002. Zuckschwerdt München S 253–259Google Scholar
  15. Eifel P, Morris M, Burke Th et al (1995) Prolonged continuous infusion cisplatin und 5 fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol 59:51–56PubMedCrossRefGoogle Scholar
  16. Emanuels AG, Koudstaal J, Burger MP et al (1999) In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymphnode metastases. Br J Cancer 80:38–43PubMedCrossRefGoogle Scholar
  17. Faul CM, Mirmow D, Huang Q et al (1997) Adjuvant radiation for vulvar carcinoma: improved local control. Int J Radiat Oncol Biol Phys 38:381–389PubMedGoogle Scholar
  18. Fine BA, Fowler LJ, Valente PT et al (1995) Minimally invasive Paget’s disease of the vulva with extensive lymph node metastases. Gynecol Oncol 57:262–265PubMedCrossRefGoogle Scholar
  19. Friedrich EJ, Wikinson EF, Fu Ys (1980) Carcinoma in situ of the vulva: A continuing challenge. Obstet Gynecol 136:801–806Google Scholar
  20. Gordiner ME, Steinhoff MM, Hogan JW et al (1997) S-Phase fraction, p53 and HER-2/neu status as predictors of nodal metastasis in early vulvar cancer. Gynecol Oncol 67:200–202CrossRefGoogle Scholar
  21. Gross G, Hageorn M, Ikenberg H et al (1985) Bowenoid papulosis: Presence of human papillomavirus (HPV) structural antigens and HPV 16-related DNA sequences. Arch Dermatol 121:858PubMedCrossRefGoogle Scholar
  22. Hacker N (2000) Vulvar cancer. In J Berek, N Hacker (eds) Practical Gynecologic Oncology. Williams & Wilkins Baltimore 3rd ed. pp 553–596Google Scholar
  23. Hacker N (1993) Conservative management of early vulvar cancer. Cancer 71:84(Suppl)1673–1677PubMedGoogle Scholar
  24. Hacker N, Berek JS, Juillard GJF et al (1993) Preoperative radiation therapy for locally advanced vulvar cancer. Cancer 54:2056CrossRefGoogle Scholar
  25. Han SC, Kim DH, Higgins SA et al (2000) Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int J Radiat Oncol Biol Phys 47:1235PubMedGoogle Scholar
  26. Hillemanns P, Untsch M, Dannecker C et al (2000) Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevolinic acid. Int J Cancer 85:649–653PubMedCrossRefGoogle Scholar
  27. Holoway AH, Rieger-Christ KM, Miner WR et al (2002) Somatic mutations of PTEN in vulvar cancer. Clin Cancer Res 6:3228–3235Google Scholar
  28. Homesley HD, Bundy BN, Sedlis A (1991) Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival. A Gynecologic Oncology Group study. Am J Obstet Gynecol 164:997–1003PubMedGoogle Scholar
  29. Homesley HD, Bundy BN, Sedlis A et al (1993) Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva. A Gynecologic Oncology Group study. Gynecol Oncol 49:279–283PubMedCrossRefGoogle Scholar
  30. Homesley HD (1985) Carcinoma of the vulva. In: Conn HF (ed) Conn’s current therapy. Saunder, Philadelphia, p85Google Scholar
  31. Hopkins MP, Reid GC, Morley GW (1990) The surgical management of recurrent squamous cell carcinoma of the vulva. Obstet Gynecol 75:1001–1005PubMedGoogle Scholar
  32. Iversen T, Aas M (1983) Lymph drainage from the vulva. Gynecol Oncol 16:179PubMedCrossRefGoogle Scholar
  33. Jones RW, Rowan DM (2000) Spontaneous regression of vulvar intraepithelial neoplasia 2–3. Obstet Gynecol 96:470–472PubMedCrossRefGoogle Scholar
  34. Kaern J, Iversen T, Trope C et al (1992) Flow cytometric DNA measurements in squamous cell carcinoma of the vulva: an important prognostic method. Int Gynecol Cancer 2:169CrossRefGoogle Scholar
  35. Koh WJ, Wallace HJ, Geer BE et al (1993) Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer. Int J Radiat Oncol Biol Phys 26:809–816PubMedGoogle Scholar
  36. Kolben M, Würschmidt F, Mauer S (2001) Multimodale Therapiekonzepte. In Kimmig R, Kürzl R (eds) Manual Vulvakarzinom des Tumorzentrums München. Zuckschwerdt München S 26–29Google Scholar
  37. Kurman RJ (1992) In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol 166:1482PubMedGoogle Scholar
  38. Kürzl R (1997) VIN: Therapeutic options. In: Micheletti L, Sideri M (eds) Proc of the ISSVD. Post-Congress, postgraduate course. Baveno, Italy Editioni MAF-Servizi, TurinGoogle Scholar
  39. Landis S, Murray T, Bolden S et al (1998) Cancer Statistics. CA — Cancer J Clin 48:6–29PubMedCrossRefGoogle Scholar
  40. Lee YY, Wilczynski SP, Chumakov A et al (1994) Carcinoma of the vulva: HPV and p53 mutations. Oncogene 9:1655–1659PubMedGoogle Scholar
  41. Magrina JF, Conti L, Atlante G et al (1998) Vulvar squamous cell cancer of the vulva: radical versus modified radical vulbar surgery. Gynecol Oncol 71:116–121PubMedCrossRefGoogle Scholar
  42. Mitchell M, Prasad C, Silva E et al (1993) Second genital primary squamous neoplasms in vulvar carcinoma: viral and histopathologic correlates. Obstet Gynecol 81:13–18PubMedGoogle Scholar
  43. Modesitt SC, Waters AB, Walton L et al (1998) Vulvar intraepithelial neoplasia III: occult cancer and impact of margin status on recurrence. Obstet Gynecol 92:962–966PubMedCrossRefGoogle Scholar
  44. Monaghan JM (1985) Management of vulvar carcinoma. In: Sheperd JH, Monaghan JM (eds) Clinical Gynecological Oncology. Blackwell, London, pp 133–153Google Scholar
  45. Moore DH, Thomas GM, Montana GS et al (1998) Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 42:79–85PubMedGoogle Scholar
  46. Obermair A, Kohlberger P, Bancher-Todesca D et al (1996) Influence of microvessel density and vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecol Oncol 63:204–209PubMedCrossRefGoogle Scholar
  47. Perez CA, Grigsby PW, Galakatos A et al (1993) Radiation therapy in the management of carcinoma of the vulva with emphasis on conservation therapy. Cancer 71:3707–3716PubMedCrossRefGoogle Scholar
  48. Petereit DG, Metha MP, Buchler DA et al (1993) Inguinofemoral radiation of N0, N1 vulvar cancer may be equivalent to lymphadenectomy if proper radiation technique is used. Int J Radiat Oncol Biol Phys 27:963–967PubMedGoogle Scholar
  49. Phillips GL, Bundy BN, Okagaki T et al (1994) Malignant melanoma of the vulva treated by radical hemivulvectomy. A prospective study of the Gynecologic Oncology Group. Cancer 73:2626–2632PubMedCrossRefGoogle Scholar
  50. Pinto AP, Lin M-C, Mutter GL et al (1999) Allelic loss in human papilloma positive and negative vulvar squamous cell carcinomas. Am J Pathol 155:1009–1015Google Scholar
  51. Russel AH, Mesic JB, Scudder SA et al (1992) Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. Gynecol Oncol 47:14–20CrossRefGoogle Scholar
  52. Schnürch H-G, Küppers V, Bender HG (1997) Vulva-Neoplasien. In Zeller WJ, zur Hausen (Hrsg) Onkologie — Grundlagen, Diagnostik, Therapie, Entwicklungen. Bd 2 ecomed Landsberg 3. ErgÄnzungsl V-211 S 1–9Google Scholar
  53. Scurry J, Flowers LC, Wistuba I et al (1998) Human papilloma virus, lichen sclerosus and vulvar squamous cell carcinoma. Int J Gynecol Cancer 8:298–306CrossRefGoogle Scholar
  54. Scurry J (1999) Does lichen sclerosus play a central role in the pathogenesis of human papillomavirus negative vulvar squamous cell carcinoma. The itch-scratch-lichen sclerosus hypothesis. Int J Gynecol Cancer 9:89–97PubMedCrossRefGoogle Scholar
  55. Sebag-Montefiori DJ, McLean C, Arnott SJ et al (1994) Treatment of advanced carcinoma of the vulva with chemoradiotherapy — can exenterative surgery be avoided? Int J Gynecol Cancer 4:150–155CrossRefGoogle Scholar
  56. Sillman FH, Sedlis A, Boyce JG (1985) A review of lower genital intraepithelial neoplasia and the use of topical 5-fluorouracil. Obstet Gynecol Surv 40:190–220PubMedCrossRefGoogle Scholar
  57. Stehmann F, Bundy B, Bell J et al (1992) Groin dissection versus groin radiation in carcinoma of the vulva: a gynecologic group study. Int J Radiat Oncol Biol Phys 24:389Google Scholar
  58. Sturgeon SR, Sherman ME (2000) Epidemiology: VIN and vulvar cancer. In: Luesly DM (ed) Cancer and Precancer of the Vulva. Arnold, London pp 1–12Google Scholar
  59. Sturgeon SR, Briton LA, Devesa SS, Kurman RJ (1992) In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol 166:1482PubMedGoogle Scholar
  60. Tateo A, Tateo S, Bernasconi C et al (1996) Use of V-Y flaps for vulvar reconstruction. Gynecol Oncol 62:203–207PubMedCrossRefGoogle Scholar
  61. Tewari K, Cappuccini F, Syed AM et al (1999) Interstitial brachytherapy in the treatment of advanced and recurrent vulvar cancer. Am J Obstet Gynecol 181:91–98PubMedCrossRefGoogle Scholar
  62. Thomas G, Bembo A, DePetrillo A et al (1989) Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol 34:263PubMedCrossRefGoogle Scholar
  63. Trimble E, Lewin J, Williams LL et al (1992) Management of vulvar melanoma. Gynecol Oncol 45:254–258PubMedCrossRefGoogle Scholar
  64. Trope C, Johnson JE, Larrson G et al (1980) Bleomycin alone or combined with mitomycin C in treatment of advanced or recurrent squamous carcinoma of the vulva. Cancer Treat Rep 64:639PubMedGoogle Scholar
  65. UICC (2002) TNM-Klassifikation maligner Tumoren. Springer Berlin, Heidelberg, New YorkGoogle Scholar
  66. Van Beurden M, van der Vange N, Ten Kate FJW et al (1998) Restricted surgical management of vulvar intraepithelial neoplasia. 3: Focus on exclusion of invasion and on relief of symptoms. Int J Gynecol Cancer 8:73PubMedCrossRefGoogle Scholar
  67. Wahlen ST, Slater J, Wagner R et al (1995) Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva. Cancer 75:2289–2294PubMedCrossRefGoogle Scholar
  68. Way S (1960) Carcinoma of the vulva. Am J Obstet Gynecol 9:692–697Google Scholar
  69. Wilkinson EJ, Kneale B, Lynch PJ (1986) Report of the ISSVD Terminology Committee. J Reprod Med 31:973–974Google Scholar
  70. Wilkinson EJ (1992) Normal histology and nomenclature of the vulva and malignant neoplasms, including VIN. Dermatol Clin 10:238Google Scholar
  71. Woodruff JD, Julian C, Puray T et al (1973) The contemporary challenge of carcinoma of the vulva. Am J Obstet Gynecol 115:677–686PubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2006

Authors and Affiliations

  • H. G. Schnürch
  • H. G. Meerpohl

There are no affiliations available

Personalised recommendations